Bal Pharma Limited BALPHARMA.NS Stock
Bal Pharma Limited Price Chart
Bal Pharma Limited BALPHARMA.NS Financial and Trading Overview
| Bal Pharma Limited stock price | 98.65 INR |
| Previous Close | 88.85 INR |
| Open | 88.5 INR |
| Bid | 88.55 INR x 0 |
| Ask | 88.8 INR x 0 |
| Day's Range | 87.5 - 92.95 INR |
| 52 Week Range | 63.35 - 104.9 INR |
| Volume | 126.37K INR |
| Avg. Volume | 56.24K INR |
| Market Cap | 1.39B INR |
| Beta (5Y Monthly) | 0.431849 |
| PE Ratio (TTM) | 52.708336 |
| EPS (TTM) | 2.21 INR |
| Forward Dividend & Yield | 1 (1.14%) |
| Ex-Dividend Date | September 14, 2022 |
| 1y Target Est | N/A |
BALPHARMA.NS Valuation Measures
| Enterprise Value | 2.59B INR |
| Trailing P/E | 52.708336 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.45669517 |
| Price/Book (mrq) | 2.157073 |
| Enterprise Value/Revenue | 0.852 |
| Enterprise Value/EBITDA | 10.323 |
Trading Information
Bal Pharma Limited Stock Price History
| Beta (5Y Monthly) | 0.431849 |
| 52-Week Change | -5.37% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 104.9 INR |
| 52 Week Low | 63.35 INR |
| 50-Day Moving Average | 82.04 INR |
| 200-Day Moving Average | 85.34 INR |
BALPHARMA.NS Share Statistics
| Avg. Volume (3 month) | 56.24K INR |
| Avg. Daily Volume (10-Days) | 33.12K INR |
| Shares Outstanding | 15.69M |
| Float | 4.59M |
| Short Ratio | N/A |
| % Held by Insiders | 66.94% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 1 |
| Trailing Annual Dividend Yield | 1.12% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0.5988 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2023 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | March 31, 2024 |
Profitability
| Profit Margin | 0.84% |
| Operating Margin (ttm) | 5.25% |
| Gross Margin | 43.20% |
| EBITDA Margin | 8.25% |
Management Effectiveness
| Return on Assets (ttm) | 3.48% |
| Return on Equity (ttm) | 4.28% |
Income Statement
| Revenue (ttm) | 3.04B INR |
| Revenue Per Share (ttm) | 195.78 INR |
| Quarterly Revenue Growth (yoy) | 11.30% |
| Gross Profit (ttm) | N/A |
| EBITDA | 251.23M INR |
| Net Income Avi to Common (ttm) | 25.72M INR |
| Diluted EPS (ttm) | 1.68 |
| Quarterly Earnings Growth (yoy) | -18.80% |
Balance Sheet
| Total Cash (mrq) | 76.12M INR |
| Total Cash Per Share (mrq) | 4.9 INR |
| Total Debt (mrq) | 1.31B INR |
| Total Debt/Equity (mrq) | 205.64 INR |
| Current Ratio (mrq) | 1.09 |
| Book Value Per Share (mrq) | 41.051 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -18435000 INR |
| Levered Free Cash Flow (ttm) | -243516000 INR |
Profile of Bal Pharma Limited
| Country | India |
| State | N/A |
| City | Bengaluru |
| Address | Lakshmi Narayan Complex |
| ZIP | 560052 |
| Phone | 91 80 4137 9500 |
| Website | https://www.balpharma.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Bal Pharma Limited manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers prescription drugs, generics, OTC products, intravenous infusion products, and bulk actives. It provides anti-infectives, pain management, respiratory care, and women's health products under the Aziwin, Ebay, Balvibe, MNF, Ocium, and Monogesic Plus Gel brands; diabetic care products under the Diabend and Diabend M Group brands; herbal/ayurvedic preparations targeting conditions, such as prostrate enlargement, renal calculi, male infertility, women health, etc. under the Stonex, Ashwamed, Prostowin, Suswas, Menoleap, and Ayursulin brands; anti-hypertensive, anti-lipidemic, and anti-obese products; skin care and bone health products; and cardiac care products under the Secremet and Servace brands. In addition, the company offers a range of APIs for therapeutic areas, such as anti-histamine, platelet inhibitor, anti-diabetic, anti convulsant, urinary incontinence, neuropathic pain, anti-allergy, anti-inflammatory, diuretic, acne treatment, etc.; and various formulations. Further, it engages in the treatment of gastrointestinal disorders; and piles, fistula, and constipation. Bal Pharma Limited was incorporated in 1987 and is based in Bengaluru, India.
Q&A For Bal Pharma Limited Stock
What is a current BALPHARMA.NS stock price?
Bal Pharma Limited BALPHARMA.NS stock price today per share is 98.65 INR.
How to purchase Bal Pharma Limited stock?
You can buy BALPHARMA.NS shares on the NSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Bal Pharma Limited?
The stock symbol or ticker of Bal Pharma Limited is BALPHARMA.NS.
Which industry does the Bal Pharma Limited company belong to?
The Bal Pharma Limited industry is Drug Manufacturers-Specialty & Generic.
How many shares does Bal Pharma Limited have in circulation?
The max supply of Bal Pharma Limited shares is 15.82M.
What is Bal Pharma Limited Price to Earnings Ratio (PE Ratio)?
Bal Pharma Limited PE Ratio is 44.63801000 now.
What was Bal Pharma Limited earnings per share over the trailing 12 months (TTM)?
Bal Pharma Limited EPS is 2.21 INR over the trailing 12 months.
Which sector does the Bal Pharma Limited company belong to?
The Bal Pharma Limited sector is Healthcare.